is mounjaro a glp-1 (tirzepatide) dual incretin agonist targeting both and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to What You Need to Know

We choose the ingredients for your new, uniquely powerful serum to perform

Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials

If your goal is to tackle oily skin and surface texture, Retinol remains a powerful tool

What lipotropic injections plausibly contribute is more modest and more defensible: correction of real deficiencies, a tolerable non-stimulant option for patients who cannot or will not take prescription weight loss medication, and a recurring touchpoint that keeps patients engaged with a supervised program